Person: KÖSE, KEMAL NACİ
Loading...
Email Address
Birth Date
Research Projects
Organizational Units
Job Title
Last Name
KÖSE
First Name
KEMAL NACİ
Name
4 results
Search Results
Now showing 1 - 4 of 4
Publication Metadata only İyonik diş fırçasının ortodontik tedavi gören hastalarda ağız hijyeni üzerindeki etkisinin araştırılması.(1998-05-20) KÖSE, KEMAL NACİ; KADİR, TANJU; YILMAZ R. S., KÖSE K. N., EFEOĞLU E., Noyan U., KURU B., BİREN S., KADİR T.Publication Metadata only The use of all-ceramic restorations to splint periodontally compromised teeth: A clinical report(MOSBY-ELSEVIER, 2005) KÖSE, KEMAL NACİ; Kuybulu, EO; Gemalmaz, D; Kose, KNThis clinical report describes the use of an all-ceramic system to restore periodontally compromised teeth. A metal-free post-and-core system and all-ceramic crowns were used to splint the teeth and fulfill the esthetic demands.Publication Metadata only Multidisciplinary approach in the treatment of subgingivally fractured anterior teeth(WILEY, 2008) KÖSE, KEMAL NACİ; Tuerker, Sebnem Beguem; Koese, Kemal NaciWith the advances in adhesive technology, dentists have gained great popularity with their esthetics treatment options. The enamel and partially dentin adhesive systems have proved their potential effect. This study presents the multidisciplinary approach in the treatment of subgingivally fractured anterior teeth. Empress II crowns were cemented entirely on the prepared root portion of a left maxillary lateral incisor and canine after orthodontic eruption. The clinical results after 2 years were successful.Publication Metadata only Expression of growth factors in the gingival crevice fluid of patients with phenytoin-induced gingival enlargement(PERGAMON-ELSEVIER SCIENCE LTD, 2004) KÖSE, KEMAL NACİ; Kuru, L; Yilmaz, S; Kuru, B; Kose, KN; Noyan, UThe mechanism underlying phenytoin (PHT)-induced gingival enlargement (GE) is not yet known. The aim of the present study was to investigate transforming growth factor-1 (TGF-beta1), platelet-derived growth factor-BB (PDGF-BB) and basic fibroblast growth factor (bFGF) profiles in the gingival crevice fluid (GCF) of patients with PHT-induced GE and to compare the results with healthy controls. Five PHT-treated patients and five healthy subjects with normal periodontal. tissue were included in this study. GCF samples were collected from (i) enlarged gingival. sites in patients receiving PHT (GE+); (ii) non-enlarged gingival sites in the same patients (GE-); (iii) normal gingival sites of healthy subjects (control). The levels of TGF-beta1, PDGF-BB and bFGF in the GCF samples were analysed by ELISA. The results showed that the total amounts of TGF-beta1 and PDGF-BB in the GE+ group were higher than in the GE- group and significantly higher than in the control group (P < 0.05). However, no significant differences were found between the groups when the concentrations of these growth factors were compared. bFGF levels were not compared as this growth factor could be detected in only 33, 41 and 44% of the GE+, GE- and control GCF samples, respectively. These results show that TGF-beta1 and PDGF-BB are readily detectable in GCF obtained from enlarged and non-enlarged sites of PHT recipients and suggest that since the amounts were markedly higher at the GE+ than the GE- sites, the systemic administration of PHT has a pronounced localised effect on the levels of these growth factors. Moreover, our findings provide evidence that both TGF-beta1 and PDGF-BB are closely associated with the clinical manifestation of PHT-induced GE. (C) 2004 Elsevier Ltd. All rights reserved.